Physician profile
Marlene M Schank
NPI 1235467887
$1,616.75
in general payments reported to CMS, 2019-2025
20 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $374 · 2023: $413 · 2024: $489 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,090.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $389.94 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Mylan Specialty L.P. | $189.65 | 2021-2024 | Yupelri |
| Lilly USA, LLC | $184.74 | 2021-2024 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $163.88 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbvie INC. | $111.56 | 2023-2024 | |
| Axsome Therapeutics, INC. | $104.92 | 2023-2025 | Auvelity |
| Sk Life Science, INC. | $79.62 | 2022 | |
| Sanofi Pasteur INC. | $48.53 | 2023-2024 | |
| Amgen INC. | $46.55 | 2024 | Otezla, Repatha |
| Pfizer INC. | $46.43 | 2023-2024 | |
| Exact Sciences Corporation | $45.88 | 2024 | Cologuard Collection Kit |
| Dexcom, INC. | $33.87 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $32.64 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.40 | 2021-2022 | |
| Boston Scientific Corporation | $23.85 | 2025 | Ingevity+ |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.13 | 2023 | Ofev |
| Jazz Pharmaceuticals INC. | $19.69 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $17.43 | 2025 | |
| Horizon Therapeutics Plc | $12.57 | 2021 | |
| Merck Sharp & Dohme LLC | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlene Schank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.